跳至主要内容
临床试验/IRCT20171030037093N30
IRCT20171030037093N30招募中3 期

A comparative study on the effect of two compounds of Propofol-Remifentanil and Propofol-Hydralazine on volume of blood loss during dacryocystorhinostomy with general anesthesia

Esfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • ASA I, II patients who are candidates for DCR surgery
  • Age range 18 to 80 years
  • No contraindication for Hydralazine, Remifentanil and Propofol
  • Consent to participate in the study

排除标准

  • Known allergies to medicines
  • Having heart disease
  • Having diabetes mellitus
  • Obvious anemia
  • Having hemoglobinopathy
  • Having polycythemia
  • Having liver disease
  • Ischemic cerebrovascular disease
  • Having respiratory failure
  • Systemic hypertension
  • Any complication that may alter the anesthesia program
  • Occurrence of complications such as heart block, etc. that prohibit or restrict the continuation of the intervention

研究者

相似试验